Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 14, 2003Blood

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

View Full Paper
Ask AI
Bookmark
Share

Authors

DTDeborah A. Thomas

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Deborah A. Thomas (2003) studied this question.

synapsesocial.com/papers/69d7370bf07a12db70b8a5bchttps://doi.org/10.1182/blood-2003-08-2958
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α Therapy1995 · 432 citations
  2. 2Risk factors for adults with Philadelphia‐chromosome‐positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real‐time quantitative reverse‐transcription polymerase chain reaction2002 · 64 citations
  3. 3Outcome of Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia2000 · 140 citations
  4. 4Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome–positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses2002 · 163 citations